Scott Kathleen D.
SEC CIK 1794284 · EDGAR
BoughtSold
Most active insiders at DRMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | $1,270 | — |
| 2 | Scott Kathleen D. | Dir | — | $13.09 |
| 3 | Van Hoose Kyri K. | SVP, CFO | — | — |
| 4 | PROEHL GERALD T | Pres, COB, CEO, Dir, 10% | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 16:15 | 2026-06-16 | DRMA | Dermata Therapeutics, Inc. | Scott Kathleen D. | Dir | S - Sale | $1.19 | -11 | 0 | -100% | -$13.09 | |
| D | 2025-08-22 | 2025-08-21 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 22.5K | +124% | +$18.8K |
| D | 2025-08-22 | 2025-08-21 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | S - Sale+OE | $15.00 | -12.5K | 10.0K | -55% | -$187.5K |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +50.0K | 57.4K | +673% | +$75.0K |
| D | 2025-05-22 | 2025-05-20 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | S - Sale+OE | $14.10 | -50.0K | 7,424 | -87% | -$705.0K |
| D | 2024-10-17 | 2024-10-16 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | S - Sale+OE | $16.00 | -12.5K | 4,949 | -72% | -$200.0K |
| D | 2024-10-17 | 2024-10-16 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 17.4K | +253% | +$18.8K |
| D | 2024-08-21 | 2024-08-20 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 25.7K | +95% | +$18.8K |
| D | 2024-08-21 | 2024-08-20 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | S - Sale+OE | $16.00 | -12.5K | 13.2K | -49% | -$200.0K |
| I | 2022-12-01 | 2022-11-29 | SPRY | ARS Pharmaceuticals, Inc. | Scott Kathleen D. | CFO | P - Purchase | $6.24 | +8,250 | 8,250 | New | +$51.5K |
| 2022-10-07 | 2022-10-06 | DRMA | Dermata Therapeutics, Inc. | Scott Kathleen D. | Dir | A - Grant | $0.00 | +11.4K | 27.1K | +72% | $0 | |
| 2022-07-08 | 2022-07-07 | DRMA | Dermata Therapeutics, Inc. | Scott Kathleen D. | Dir | A - Grant | $0.00 | +9,960 | 15.8K | +171% | $0 | |
| 2022-04-08 | 2022-04-07 | DRMA | Dermata Therapeutics, Inc. | Scott Kathleen D. | Dir | A - Grant | $0.00 | +5,826 | 5,826 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations